PSAT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.11819500512456E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.21550547405036E-11 |
Normal-vs-Stage2 |
2.74269496003399E-11 |
Normal-vs-Stage3 |
2.93020052666293E-10 |
Normal-vs-Stage4 |
5.98610000013267E-07 |
Stage1-vs-Stage2 |
6.516200E-01 |
Stage1-vs-Stage3 |
1.026330E-02 |
Stage1-vs-Stage4 |
5.278400E-03 |
Stage2-vs-Stage3 |
1.202030E-01 |
Stage2-vs-Stage4 |
1.423950E-02 |
Stage3-vs-Stage4 |
9.518400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.50539630445246E-11 |
Normal-vs-AfricanAmerican |
3.95820043408435E-10 |
Normal-vs-Asian |
2.78659999963793E-07 |
Caucasian-vs-AfricanAmerican |
6.935200E-01 |
Caucasian-vs-Asian |
9.450200E-01 |
AfricanAmerican-vs-Asian |
8.061800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.42350020659876E-10 |
Normal-vs-Female |
3.67630370590177E-11 |
Male-vs-Female |
2.135400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.135380E-03 |
Normal-vs-Age(41-60Yrs) |
5.32850430445819E-11 |
Normal-vs-Age(61-80Yrs) |
6.68920474566903E-11 |
Normal-vs-Age(81-100Yrs) |
7.44940000019234E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.343200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.539000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.962600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.734400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.452600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.968200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.08371122975859E-13 |
Normal-vs-Grade 2 |
1.32790445306341E-11 |
Normal-vs-Grade 3 |
5.22329957064471E-11 |
Normal-vs-Grade 4 |
2.31210000001258E-06 |
Grade 1-vs-Grade 2 |
1.222360E-03 |
Grade 1-vs-Grade 3 |
2.2667999999948E-05 |
Grade 1-vs-Grade 4 |
4.03050000041816E-07 |
Grade 2-vs-Grade 3 |
1.829050E-01 |
Grade 2-vs-Grade 4 |
1.013010E-04 |
Grade 3-vs-Grade 4 |
8.369600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.54829490842212E-12 |
Normal-vs-ccB subtype |
1.32959998566662E-09 |
ccA subtype-vs-ccB subtype |
1.10839999956092E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.11429976357158E-10 |
Normal-vs-N1 |
2.505600E-01 |
N0-vs-N1 |
5.777500E-02 |
|
|